Alphamab Oncology has announced the grant of award shares under its Restricted Share Award Scheme, as disclosed in a recent filing with The Stock Exchange of Hong Kong Limited. The company aims to recognize and reward the contributions of its Award Directors, providing them with shares as part of their compensation. The shares granted to the Award Directors do not have specific performance targets, aligning with the company's remuneration policy. This initiative is part of the company's efforts to closely align the interests of its shareholders, the company, and its directors. The announcement, made by Chairman Dr. Xu Ting, highlights the company's focus on its continual operation and long-term growth.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。